Cargando…

Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes

Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira-Hermosillo, Aldo, Molina-Ayala, Mario, Ramírez-Rentería, Claudia, Vargas, Guadalupe, Gonzalez, Baldomero, Isibasi, Armando, Archundia-Riveros, Irma, Mendoza, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530274/
https://www.ncbi.nlm.nih.gov/pubmed/26273680
http://dx.doi.org/10.1155/2015/972073
_version_ 1782384889361858560
author Ferreira-Hermosillo, Aldo
Molina-Ayala, Mario
Ramírez-Rentería, Claudia
Vargas, Guadalupe
Gonzalez, Baldomero
Isibasi, Armando
Archundia-Riveros, Irma
Mendoza, Victoria
author_facet Ferreira-Hermosillo, Aldo
Molina-Ayala, Mario
Ramírez-Rentería, Claudia
Vargas, Guadalupe
Gonzalez, Baldomero
Isibasi, Armando
Archundia-Riveros, Irma
Mendoza, Victoria
author_sort Ferreira-Hermosillo, Aldo
collection PubMed
description Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conducted a cross-sectional evaluation of all patients in our type 1 diabetes clinic from January 2012 to January 2013. Patients were considered to have metabolic syndrome when they fulfilled the joint statement criteria and were evaluated for clinical, biochemical, and immunological features. Methods. We determined serum IL-6, IL-8, IL-10, and TNF with flow cytometry and adiponectin and resistin concentrations with enzyme linked immunosorbent assay in patients with and without metabolic syndrome. We also compared estimated glucose disposal rate between groups. Results. We tested 140 patients. Forty-four percent fulfilled the metabolic syndrome criteria (n = 61), 54% had central obesity, 30% had hypertriglyceridemia, 29% had hypoalphalipoproteinemia, and 19% had hypertension. We observed that resistin concentrations were higher in patients with MS. Conclusion. We found a high prevalence of MS in Mexican patients with T1D. The increased level of resistin may be related to the increased fat mass and could be involved in the development of insulin resistance.
format Online
Article
Text
id pubmed-4530274
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45302742015-08-13 Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes Ferreira-Hermosillo, Aldo Molina-Ayala, Mario Ramírez-Rentería, Claudia Vargas, Guadalupe Gonzalez, Baldomero Isibasi, Armando Archundia-Riveros, Irma Mendoza, Victoria J Diabetes Res Research Article Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conducted a cross-sectional evaluation of all patients in our type 1 diabetes clinic from January 2012 to January 2013. Patients were considered to have metabolic syndrome when they fulfilled the joint statement criteria and were evaluated for clinical, biochemical, and immunological features. Methods. We determined serum IL-6, IL-8, IL-10, and TNF with flow cytometry and adiponectin and resistin concentrations with enzyme linked immunosorbent assay in patients with and without metabolic syndrome. We also compared estimated glucose disposal rate between groups. Results. We tested 140 patients. Forty-four percent fulfilled the metabolic syndrome criteria (n = 61), 54% had central obesity, 30% had hypertriglyceridemia, 29% had hypoalphalipoproteinemia, and 19% had hypertension. We observed that resistin concentrations were higher in patients with MS. Conclusion. We found a high prevalence of MS in Mexican patients with T1D. The increased level of resistin may be related to the increased fat mass and could be involved in the development of insulin resistance. Hindawi Publishing Corporation 2015 2015-07-27 /pmc/articles/PMC4530274/ /pubmed/26273680 http://dx.doi.org/10.1155/2015/972073 Text en Copyright © 2015 Aldo Ferreira-Hermosillo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ferreira-Hermosillo, Aldo
Molina-Ayala, Mario
Ramírez-Rentería, Claudia
Vargas, Guadalupe
Gonzalez, Baldomero
Isibasi, Armando
Archundia-Riveros, Irma
Mendoza, Victoria
Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
title Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
title_full Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
title_fullStr Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
title_full_unstemmed Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
title_short Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
title_sort inflammatory cytokine profile associated with metabolic syndrome in adult patients with type 1 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530274/
https://www.ncbi.nlm.nih.gov/pubmed/26273680
http://dx.doi.org/10.1155/2015/972073
work_keys_str_mv AT ferreirahermosilloaldo inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT molinaayalamario inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT ramirezrenteriaclaudia inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT vargasguadalupe inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT gonzalezbaldomero inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT isibasiarmando inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT archundiariverosirma inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes
AT mendozavictoria inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes